|

No intervention Clinical Trials

2 actively recruiting trials

Pipeline

Phase 4: 1

Top Sponsors

  • Takeda1
  • Helsinki University Central Hospital1

Indications

  • Lung Cancer2
  • Cancer2
  • Liver Disease1
  • Bleeding1
  • Embolism, Pulmonary1

Other2 trials

A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY
Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.